Literature DB >> 16001269

[Bibliometric analysis of anaesthetic molecular biology research in Germany, Austria and Switzerland].

K Schreiber1, C H Kindler.   

Abstract

BACKGROUND: In the last 20 years molecular biology has expanded the horizons of medical research including anaesthesia. Preoperative identification of genetic disorders relevant to anaesthesia or increased perioperative risk will be available in the near future using molecular biology techniques. There has been a global increase of such publications, but the contributions from Germany, Switzerland and Austria are unknown.
MATERIAL AND METHODS: An internet-based medline search was used to analyse specific features such as year of publication, journal and origin of molecular biology articles produced by German, Swiss and Austrian anaesthesia institutions from 1988 to 2002.
RESULTS: During the study period 121 articles from German institutions were published, 18 from Switzerland and 5 from Austria, corresponding to 10%, 1.5% and 0.4%, respectively, of global publications. In Germany the number of anaesthesia publications with a molecular biology content has continuously increased, but in Switzerland and Austria the numbers have remained constant. The majority of articles were published in high-impact non-anaesthesia journals. DISCUSSION AND
CONCLUSION: The results of this study show the quantitative development of molecular biology research that has been done in anaesthesia institutions in Germany, Switzerland and Austria from 1988 to 2002. A continuous increase of publications with a molecular biology content occurred only in Germany.

Entities:  

Mesh:

Year:  2005        PMID: 16001269     DOI: 10.1007/s00101-005-0892-4

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  26 in total

1.  [German publications in leading English language journals].

Authors:  W H Maleck; J Boldt; K P Koetter
Journal:  Dtsch Med Wochenschr       Date:  2001-01-19       Impact factor: 0.628

2.  [How well-positioned is a publication in the German language?].

Authors:  G V Dietrich; G Hempelmann
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2000-09       Impact factor: 0.698

3.  [German language publications of German university departments of anesthesiology].

Authors:  W H Maleck; J Boldt; R Wickenhäuser
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2000-09       Impact factor: 0.698

4.  Genotype-phenotype comparison of the Swiss malignant hyperthermia population.

Authors:  T Girard; A Urwyler; K Censier; C R Mueller; F Zorzato; S Treves
Journal:  Hum Mutat       Date:  2001-10       Impact factor: 4.878

5.  Research output in anaesthesia: a quantitative ranking.

Authors:  M Rahman; J Sakamoto; T Fukui
Journal:  Anaesthesia       Date:  2002-12       Impact factor: 6.955

Review 6.  Influence of genotype on perioperative risk and outcome.

Authors:  Stephan Ziegeler; Byron E Tsusaki; Charles D Collard
Journal:  Anesthesiology       Date:  2003-07       Impact factor: 7.892

7.  Platelet PlA2 polymorphism and platelet activation are associated with increased troponin I release after cardiopulmonary bypass.

Authors:  Christine S Rinder; Joseph P Mathew; Henry M Rinder; J Greg Howe; Manuel Fontes; Jill Crouch; Stephen Pfau; Parag Patel; Brian R Smith
Journal:  Anesthesiology       Date:  2002-11       Impact factor: 7.892

8.  Geography of anaesthesiology publication.

Authors:  J Eldor
Journal:  Acta Anaesthesiol Scand       Date:  1994-05       Impact factor: 2.105

9.  Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.

Authors:  Soledad Levano; Hans Ginz; Martin Siegemund; Miodrag Filipovic; Evgueni Voronkov; Albert Urwyler; Thierry Girard
Journal:  Anesthesiology       Date:  2005-03       Impact factor: 7.892

Review 10.  [Gene polymorphism in intensive care patients. Is the course of disease predetermined?].

Authors:  S Ziegeler; S Kleinschmidt; C D Collard
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.